September is Ovarian Cancer Awareness Month. Here’s a round-up of the latest news and updates in this disease space:
- Ovarian cancer is known as the deadliest gynecologic cancer in the US, given that it is not usually detected or diagnosed until it has reached advanced stages. But heavily pre-treated patients may have a new treatment option to extend their lives. Learn more about a recent study examining how Zejula (niraparib) prolongs life for patients with ovarian cancer who have already undergone four or more rounds of chemotherapy.
- Many patients struggle with the side effects of gynecologic malignancies, including ovarian cancer. In our Recent Women’s Cancers issue, we shared the stories of some of these patients and explored what can be done to address them.
- With more women living longer with ovarian cancer, it is increasingly being seen as a chronic disease. We recently took a closer look at how the evolving treatment landscape and the involvement of genetic testing are shaping the future of ovarian cancer.
- Newly diagnosed? One expert shared her tips on how to deal with a new ovarian cancer diagnosis, including a list of questions to ask as active participants in one’s own care.
- The practice of treating ovarian cancer largely through surgery is still an imperfect science. But a new ‘smart’ knife that helps surgeons distinguish healthy tissue from tumor in real-time could change the landscape of surgical ovarian cancer treatment for the better.
For our full coverage on this disease, be sure to visit our Ovarian Cancer News and Updates section.